ライフサイエンスコーパス: healthcare research

1 zed population cosponsored by the Agency for Healthcare Research.

2 the equivalent parallels and track record in healthcare research.

3 recent clinical trials, patient outcomes and healthcare research.

4 l challenges of using Twitter in nursing and healthcare research.

5 ng patient reported outcomes instruments for healthcare research.

6 and for robust large-scale data analysis in healthcare research.

7 ng the need for prioritising NPH in national healthcare research agendas.

8 ndations to address PRO respondent burden in healthcare research and clinical practice.

9 Netherlands Organisation for Healthcare Research and Development and Belgian Health C

10 promise privacy-preserving data sharing for healthcare research and development.

11 ypes of prespecified locations to facilitate healthcare research and patient care.

12 rvices Task Force (1 review), the Agency for Healthcare Research and Quality (1 review), the Cochrane

13 st and Utilization Project of the Agency for Healthcare Research and Quality (2006-2011).

14 ey types of criticism against the Agency for Healthcare Research and Quality (AHRQ) and the Centers f

15 el Survey (MEPS), provided by the Agency for Healthcare Research and Quality (AHRQ) for 2010 to calcu

16 ting input on PCCP, posted by the Agency for Healthcare Research and Quality (AHRQ) in 2022.

17 The Agency for Healthcare Research and Quality (AHRQ) Learning Health S

18 The Agency for Healthcare Research and Quality (AHRQ) pediatric quality

19 e Center (EPC) program within the Agency for Healthcare Research and Quality (AHRQ) provides detailed

20 inghouse and in print through the Agency for Healthcare Research and Quality (AHRQ) Publications Clea

21 The Agency for Healthcare Research and Quality (AHRQ) Safety Program fo

22 , median household income and the Agency for Healthcare Research and Quality (AHRQ) Socioeconomic Sta

23 ionwide Inpatient Sample from the Agency for Healthcare Research and Quality (AHRQ), we evaluated the

24 he NYC mean with inclusion of the Agency for Healthcare Research and Quality (AHRQ)-validated SES ind

25 and Utilization Project from the Agency for Healthcare Research and Quality (AHRQ).

26 Agency for Healthcare Research and Quality (AHRQ).

27 nal Inpatient Sample (NIS) of the Agency for Healthcare Research and Quality (AHRQ).

28 s through a project funded by the Agency for Healthcare Research and Quality (AHRQ).

29 prepared under contract with the Agency for Healthcare Research and Quality (AHRQ); 2) presentations

30 om 31 states was conducted, using Agency for Healthcare Research and Quality 2021 Healthcare Cost and

31 standardized forms, staff of the Agency for Healthcare Research and Quality abstracted data on study

32 ture on the topic provided by the Agency for Healthcare Research and Quality and an extensive bibliog

33 Agency for Healthcare Research and Quality and National Cancer Inst

34 Agency for Healthcare Research and Quality and National Heart, Lung

35 Agency for Healthcare Research and Quality and National Institute o

36 Agency for Healthcare Research and Quality and National Institute o

37 Agency for Healthcare Research and Quality and National Institutes

38 Primary Funding Source: Agency for Healthcare Research and Quality and National Science Fou

39 Agency for Healthcare Research and Quality and National Science Fou

40 , and additional funding from the Agency for Healthcare Research and Quality and private philanthropy

41 Agency for Healthcare Research and Quality and RAND Corporation.

42 y indicators (PSI) defined by the Agency for Healthcare Research and Quality and six experimental PSI

43 Agency for Healthcare Research and Quality and the Harvard Program

44 INTRODUCTION: The Agency for Healthcare Research and Quality and the Leapfrog Group u

45 Agency for Healthcare Research and Quality and the National Institu

46 The Agency for Healthcare Research and Quality and the National Institu

47 The Agency for Healthcare Research and Quality and the National Institu

48 Agency for Healthcare Research and Quality and the U.S. Department

49 recent landmark reports from the Agency for Healthcare Research and Quality are presented.

50 Safety Indicators (PSIs) from the Agency for Healthcare Research and Quality are validated measures o

51 nsive care units in Michigan, the Agency for Healthcare Research and Quality awarded a grant to sprea

52 th care database sponsored by the Agency for Healthcare Research and Quality between 1999 and 2013.

53 y was assessed using 2 tools: (1) Agency for Healthcare Research and Quality checklist; and (2) Natio

54 Agency for Healthcare Research and Quality class A controlled trial

55 deline Clearinghouse (NGC) of the Agency for Healthcare Research and Quality clearly indicate the ext

56 The Agency for Healthcare Research and Quality commissioned 2 systemati

57 as identified using data from the Agency for Healthcare Research and Quality compendium files, verifi

58 d among 556 health systems in the Agency for Healthcare Research and Quality Compendium of US Health

59 In 2011, a report released by the Agency for Healthcare Research and Quality concluded that, although

60 The Agency for Healthcare Research and Quality conducted systematic rev

61 f Health (NIH) institutes and the Agency for Healthcare Research and Quality convened a workshop invo

62 We evaluated QIs using Agency for Healthcare Research and Quality criteria.

63 This cross-sectional study uses Agency for Healthcare Research and Quality data to compare incidenc

64 icare reimbursement rates and the Agency for Healthcare Research and Quality Database were used to es

65 ngs of a technical report for the Agency for Healthcare Research and Quality describing MAT models of

66 Although Agency for Healthcare Research and Quality disease severity and mor

67 ioned as a technical brief by the Agency for Healthcare Research and Quality Effective Health Care Pr

68 the best available evidence, the Agency for Healthcare Research and Quality established a network of

69 In 2003, the Agency for Healthcare Research and Quality established Patient Safe

70 The 2001 Agency for Healthcare Research and Quality Evidence Report dismissi

71 An Agency for Healthcare Research and Quality evidence report of studi

72 A 2001 Agency for Healthcare Research and Quality Evidence Report on patie

73 cians nominated this topic to the Agency for Healthcare Research and Quality Evidence-Based Practice

74 ational Inpatient Sample from the Agency for Healthcare Research and Quality for the years 2010-2014.

75 National Institute of Health and Agency for Healthcare Research and Quality funded a two-state colla

76 The Agency for Healthcare Research and Quality has devoted a substantia

77 Data from the Agency for Healthcare Research and Quality Healthcare Costs and Uti

78 The Agency for Healthcare Research and Quality Hospital Survey on Patie

79 ective Health Care Program of the Agency for Healthcare Research and Quality involved stakeholders in

80 rom the nationally representative Agency for Healthcare Research and Quality Kids' Inpatient Database

81 events were operationalized using Agency for Healthcare Research and Quality measure specifications.

82 vidence (SOE) was graded with the Agency for Healthcare Research and Quality Methods Guide for Effect

83 ence (SoE) was assessed using the Agency for Healthcare Research and Quality Methods Guide.

84 I-90 scores were calculated using Agency for Healthcare Research and Quality modules.

85 tay; receipt of cancer screening; Agency for Healthcare Research and Quality patient safety indicator

86 We used Agency for Healthcare Research and Quality Patient Safety Indicator

87 nce-based Practice Centers in the Agency for Healthcare Research and Quality program produced 11 repo

88 Web site and in print through the Agency for Healthcare Research and Quality Publications Clearinghou

89 BASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relev

90 BASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relev

91 BASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relev

92 BASE, the Cochrane Collaboration, Agency for Healthcare Research and Quality reports, and other relev

93 sh from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selec

94 The Agency for Healthcare Research and Quality Safety Program appeared

95 SES was measured using the Agency for Healthcare Research and Quality SES index using data fro

96 and nSES was calculated using the Agency for Healthcare Research and Quality SES index, which combine

97 Indicators were calculated using Agency for Healthcare Research and Quality software (Win QI, versio

98 The Agency for Healthcare Research and Quality sponsored an internation

99 tool, articles were converted to Agency for Healthcare Research and Quality standards of good, fair,

100 We used the Agency for Healthcare Research and Quality State Inpatient Database

101 Modification billing data from 3 Agency for Healthcare Research and Quality State Inpatient Database

102 ase of Systematic Reviews and the Agency for Healthcare Research and Quality Systematic Review Data R

103 RECENT DATA: Evidence from a 2011 Agency for Healthcare Research and Quality systematic review primar

104 The Agency for Healthcare Research and Quality Technology Assessment Pr

105 ategories using software from the Agency for Healthcare Research and Quality to describe clinically r

106 eport through a contract with the Agency for Healthcare Research and Quality to facilitate the discus

107 eport through a contract with the Agency for Healthcare Research and Quality to facilitate the worksh

108 and Utilization Project from the Agency for Healthcare Research and Quality was analyzed.

109 The Agency for Healthcare Research and Quality's (AHRQ) Evidence-Based

110 then screened for iAEs using the Agency for Healthcare Research and Quality's 15 Patient Safety Indi

111 The Agency for Healthcare Research and Quality's Evidence-based Practic

112 used data from the 2019 and 2020 Agency for Healthcare Research and Quality's Healthcare Cost and Ut

113 to December 2021 identified in the Agency of Healthcare Research and Quality's Healthcare Cost and Ut

114 hospital admissions data from the Agency for Healthcare Research and Quality's National Inpatient Sam

115 mote performance improvement, the Agency for Healthcare Research and Quality's National Quality Measu

116 d a retrospective analysis of the Agency for Healthcare Research and Quality's Nationwide In-patient

117 primary outcomes, we applied the Agency for Healthcare Research and Quality's Patient Safety Indicat

118 y surgical complication (from the Agency for Healthcare Research and Quality's patient safety indicat

119 e main outcomes were 10 of the US Agency for Healthcare Research and Quality's patient safety indicat

120 DLINE (1966 to October 2012), the Agency for Healthcare Research and Quality's Patient Safety Network

121 s cohort study used data from the Agency for Healthcare Research and Quality's Quality and Safety Rev

122 lity zip codes were linked to the Agency for Healthcare Research and Quality's Social Determinants of

123 re and Medicaid Services) and the Agency for Healthcare Research and Quality's State Inpatient Databa

124 stroke using definitions from the Agency for Healthcare Research and Quality's stroke mortality Inpat

125 res were categorized by using the Agency for Healthcare Research and Quality's supported Outcome Meas

126 27 identified measures using the Agency for Healthcare Research and Quality's supported Outcome Meas

127 om the State Inpatient Databases (Agency for Healthcare Research and Quality), including >700,000 RSV

128 om the State Inpatient Databases (Agency for Healthcare Research and Quality).

129 sed Safety Program, funded by the Agency for Healthcare Research and Quality, aimed to reduce cathete

130 d), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and CINAHL for selected

131 US National Institutes of Health, Agency for Healthcare Research and Quality, and Health Resources an

132 itz Foundation for Social Policy, Agency for Healthcare Research and Quality, and National Institute

133 National Science Foundation, Agency for Healthcare Research and Quality, and National Institutes

134 he National Institutes of Health, Agency for Healthcare Research and Quality, and Office of the Secre

135 , the Cochrane Collaboration, the Agency for Healthcare Research and Quality, and other relevant data

136 EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected data

137 EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected data

138 EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected data

139 d), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected data

140 EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected data

141 .S. Food and Drug Administration, Agency for Healthcare Research and Quality, and Public Health Agenc

142 sease Control and Prevention, the Agency for Healthcare Research and Quality, and the National Cancer

143 National Institutes of Health, Agency for Healthcare Research and Quality, Children's Discovery In

144 MEDLINE, EMBASE, Biosis, the Agency for Healthcare Research and Quality, National Guideline Clea

145 Agency for Healthcare Research and Quality, National Institutes of

146 The Agency for Healthcare Research and Quality, the National Institute

147 PRIMARY FUNDING SOURCE: The Agency for Healthcare Research and Quality, the United Health Found

148 Under the auspices of the Agency for Healthcare Research and Quality, the United States Preve

149 se Control and Prevention, the US Agency for Healthcare Research and Quality, the US Health Resources

150 Agency for Healthcare Research and Quality, United Health Foundatio

151 isease Control and Prevention, US Agency for Healthcare Research and Quality, US Health Resources and

152 ration pneumonitis, or any of the Agency for Healthcare Research and Quality-defined ambulatory care

153 used practice-level data from the Agency for Healthcare Research and Quality-funded EvidenceNOW initi

154 re and Medicaid Services, and the Agency for Healthcare Research and Quality-have heightened nationwi

155 itis, which was defined using the Agency for Healthcare Research and Quality-specified International

156 an interagency agreement with the Agency for Healthcare Research and Quality.

157 sease Control and Prevention, and Agency for Healthcare Research and Quality.

158 on criteria and risk model of the Agency for Healthcare Research and Quality.

159 on the procedure outlined by the Agency for Healthcare Research and Quality.

160 lization Project, compiled by the Agency for Healthcare Research and Quality.

161 d Translational Sciences, and the Agency for Healthcare Research and Quality.

162 forts through a contract with the Agency for Healthcare Research and Quality.

163 Agency for Healthcare Research and Quality.

164 eport through a contract with the Agency for Healthcare Research and Quality.

165 Primary Funding Source: Agency for Healthcare Research and Quality.

166 st and Utilization Project of the Agency for Healthcare Research and Quality.

167 National Institutes of Health and Agency for Healthcare Research and Quality.

168 l specifications published by the Agency for Healthcare Research and Quality.

169 grading scheme recommended by the Agency for Healthcare Research and Quality.

170 ational Institutes of Health, and Agency for Healthcare Research and Quality.

171 PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

172 ational Institutes of Health, and Agency for Healthcare Research and Quality.

173 on rates using CDC data, and used Agency for Healthcare Research and Quality/Healthcare Cost and Util

174 r Medicare and Medicaid Services; Agency for Healthcare Research and Quality; and US Department of Ve

175 Agency for Healthcare Research and Quality; Canadian Institutes of

176 Agency for Healthcare Research and Quality; National Heart, Lung, a

177 Ethical considerations in healthcare research are paramount, but current HIPAA imp

178 osphates impact nearly every major aspect of healthcare research from DNA sequencing to drug discover

179 ng methodological frameworks used to measure healthcare research impact and to summarise the common t

180 Rosenkranz Prize for Healthcare Research in Developing Countries and US Natio

181 overall score on the Art of Medicine survey (HealthCare Research, Inc., Denver, Colorado), which meas

182 at the University of Minnesota, the Hennepin Healthcare Research Institute, and the US National Insti

183 t appropriate way of measuring the impact of healthcare research is subject to debate.

184 National Institute of Healthcare Research, JP Moulton Charitable Foundation, U

185 es of eight patient advocacy groups and five healthcare-research specialists developed the survey.

186 ted outcomes (PROs) are increasingly used in healthcare research to provide evidence of the benefits